Literature DB >> 10151967

Measuring human betterment through avoidable mortality: a case for universal health care in the USA.

J J Hisnanick1, D A Coddington.   

Abstract

The USA system of health care has begun a monumental change that will affect everyone, irrespective of their socioeconomic status, professional status or pre-existing health insurance status. Whatever type of plan is finally implemented through the legislative process, there will need to be a way to evaluate its success (or failure). One way to evaluate the plan's effectiveness is through its impact on human betterment as viewed by a reduction in 'avoidable mortality' for those most in need of health care; the poor and uninsured. For one USA minority population, universal health care has improved human betterment by reducing avoidable mortality, even in the face of a severe burden of poverty.

Entities:  

Mesh:

Year:  1995        PMID: 10151967     DOI: 10.1016/0168-8510(94)00715-q

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  4 in total

1.  Avoidable mortality in the United States and Canada, 1980-1996.

Authors:  Douglas G Manuel; Yang Mao
Journal:  Am J Public Health       Date:  2002-09       Impact factor: 9.308

2.  Commentary: approaches, strengths, and limitations of avoidable mortality.

Authors:  Glòria Pérez; Maica Rodríguez-Sanz; Eva Cirera; Katherine Pérez; Rosa Puigpinós; Carme Borrell
Journal:  J Public Health Policy       Date:  2014-03-13       Impact factor: 2.222

3.  Historical trends and regional differences in all-cause and amenable mortality among American Indians and Alaska Natives since 1950.

Authors:  Stephen J Kunitz; Mark Veazie; Jeffrey A Henderson
Journal:  Am J Public Health       Date:  2014-04-22       Impact factor: 9.308

4.  Strategic approaches to enhanced health service delivery for Aboriginal and Torres Strait Islander people with chronic illness: a qualitative study.

Authors:  Clive Aspin; Ngiare Brown; Tanisha Jowsey; Laurann Yen; Stephen Leeder
Journal:  BMC Health Serv Res       Date:  2012-06-08       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.